Cini John K. - Insider Non-Derivative Transactions at Sonnet BioTherapeutics Holdings, Inc. (SONN) - (SEC)

Updated on December 12, 2024.

According to recent SEC insider information filed on Jan 7, 2023, Cini John K.'s relationship to Sonnet BioTherapeutics Holdings, Inc. (SONN) is Officer (Chief Scientific Officer), and currently has 40,271 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other SONN insiders.

Data Source: SEC.
Cini John K. - Insider Non-Derivative Transactions of SONN Common Stock
Cini John K. - Insider Non-Derivative Transactions at SONN
Items per page:
0 of 0
Date Transaction No. of Shares Price Per Share Shares Owned After Transactions
Jan 8, 2023 Disposition -- (Common Stock) 18551 0 21720
Jan 8, 2023 Acquisition -- (Common Stock) 18551 0 40271